Albuleukin

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug NameAlbuleukin
Drug Alias Namealbumin-based IL-2 fusion protein (HGS)interleukin-2/HSA conjugate (Human Genome Sciences)albumin-based IL-2 fusion protein (Principia)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrincipia Pharmaceutical CorpHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A